News Focus
News Focus
icon url

kris_kade

12/24/15 10:12 AM

#198595 RE: DewDiligence #198593

Thanks for the synopsis. EGRX is a great LT stock to own going into 2016.
icon url

biocqr

12/24/15 10:22 AM

#198596 RE: DewDiligence #198593

EGRX selling off... down 3.5%. Was there something neg in the PR or is this sell on news?

Is this below expectations?...

Eagle expects to begin shipping Docetaxel Injection in January 2016. Eagle estimates that annual sales of generic docetaxel are approximately $75 million.

icon url

DewDiligence

01/02/16 8:04 PM

#198710 RE: DewDiligence #198593

EGRX finishes 2015 +472%—tops among drug/biotech stocks. Moral: A profitable biotech investment doesn't have to be sexy.